#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fabry's disease Central nervous system lymphoma Thalassaemia alpha Anaplastic large cell lymphoma T- and null-cell types Multifocal motor neuropathy Hodgkin's disease recurrent Encephalopathy neonatal Familial haemophagocytic lymphohistiocytosis Malignant peritoneal neoplasm Aspergillus infection Malignant melanoma Acromegaly Hypochromic anaemia Acute lymphocytic leukaemia recurrent Pleomorphic liposarcoma More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma Metachromatic leukodystrophy – Life with Disease Crigler-Najjar syndrome Methylmalonic acidaemia – Life with Disease Primary mediastinal large B-cell lymphoma Mantle cell lymphoma stage IV – Treatment Skin angiosarcoma – Trials in Disease Congenital generalised lipodystrophy – Basic Information Immunodeficiency congenital Leukoencephalopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Relebactam Dexamethasone Onasemnogene Abeparvovec Acetic Acid, Glacial Fampridine Opevesostat Cusatuzumab Bevacizumab Methylprednisolone Triptorelin Aup1602-C Spironolactone Clonidine Hydrochloride Alisertib Sodium Serpina1(Human)-Aav8-1 Amoxicillin Trihydrate Cefuroxime Sodium Abiraterone Acetate Lamivudine AZD6234 More therapies…

    Learn about Your Condition

    Dengue fever Migraine with aura Renal cancer metastatic Multiple sclerosis relapse Sarcoma Facial paresis Fontan procedure Non-obstructive cardiomyopathy Atrophic vulvovaginitis Iron overload Kawasaki's disease Hepatic adenoma Cystic fibrosis lung Essential thrombocythaemia Acoustic neuroma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 152, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Ireland +4

  • Study on the Safety and Immune Response of rBCG-N-RSV Vaccine Compared to BCG Vaccine in Adults Over 60 with Respiratory Syncytial Virus (RSV) Concerns

    Recruiting

    2 1 1 1
    Greece

  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Adagrasib
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Croatia France Germany +9

  • Study to Find Treatments for Chronic Kidney Disease Using Finerenone in Patients with Standard Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Finerenone
    Greece Spain

  • Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

    Recruiting

    3 1
    Investigated Drugs:
    • OMECAMTIV MECARBIL
    France Germany Greece Italy Poland Spain

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alectinib Hydrochloride
    • Nvl-655
    Austria Belgium Czechia Denmark France Germany +7

  • Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Rilzabrutinib
    Belgium France Germany Greece Italy The Netherlands +1

  • Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Belgium Bulgaria Denmark France Greece Hungary +3

  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    • Metastatic gastric cancer
    • Oesophageal cancer metastatic
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
    • Pembrolizumab
    Germany Greece Italy Poland Portugal Romania +1
Previous Page
1 … 8 9 10 11 12 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!